COMP <GO>
AORT vs TNDM // DIVIDEND YIELD & FCF PAYOUT SAFETY
Artivion Inc. (NYSE) VS. Tandem Diabetes Care Inc. (NASDAQ) • 15-METRIC TALLY: AORT 8
— TNDM 2
■ METRIC PARITY
LAST: $23.58 (+4.43%) • MKT CAP: $1.10B
dividend-safety
0.00%
LAST: $18.67 (-2.30%) • MKT CAP: $1.33B
dividend-safety
0.00%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (AORT VS. TNDM)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | AORT | TNDM | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 64.40% | 53.80% | +10.60 | AORT | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 4.50% | -35.00% | +39.50 | AORT | /roic <GO> |
| EV/EBITDA & P/E Valuation | 19.3x | — | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | 0.07% | -2.15% | +2.22 | AORT | /fcf-yield <GO> |
| Operating Margin | 7.60% | -18.50% | +26.10 | AORT | /operating-margins <GO> |
| Net Profit Margin | 2.20% | -20.20% | +22.40 | AORT | /net-margins <GO> |
| Revenue Growth (YoY) | 13.60% | 7.90% | +5.70 | AORT | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety ACTIVE | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 2.46 | 0.20 | +2.26 | AORT | /balance-sheet <GO> |
| Piotroski F-Score Quality | 9/9 | 4/9 | +5.00 | AORT | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 47.0 | 59.6 | -12.60 | TNDM | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | 98.3x | — | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $1.10B | $1.33B | -$228.7M | TNDM | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | AORT REV | TNDM REV | AORT GROSS % | TNDM GROSS % | AORT FCF | TNDM FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $441.3M | $1.01B | 64.4% | 53.8% | $839.0K | -$29.7M |
| FY 2024 | $388.5M | $940.2M | 64.0% | 52.1% | $11.0M | $5.0M |
| FY 2023 | $354.0M | $747.7M | — | — | $18.8M | -$31.8M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
AORT // BETA —
TNDM // BETA —